Polymer-Temozolomide Conjugates as Therapeutics for Treating Glioblastoma

about

Polymer-Temozolomide Conjugates as Therapeutics for Treating Glioblastoma

Item

http://www.wikidata.org/entity/Q57814961

description

im Oktober 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 15 October 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

Polymer-Temozolomide Conjugates as Therapeutics for Treating Glioblastoma

@en

Polymer-Temozolomide Conjugates as Therapeutics for Treating Glioblastoma

@nl

type

Item

label

Polymer-Temozolomide Conjugates as Therapeutics for Treating Glioblastoma

@en

Polymer-Temozolomide Conjugates as Therapeutics for Treating Glioblastoma

@nl

prefLabel

Polymer-Temozolomide Conjugates as Therapeutics for Treating Glioblastoma

@en

Polymer-Temozolomide Conjugates as Therapeutics for Treating Glioblastoma

@nl

P1476

Polymer-Temozolomide Conjugates as Therapeutics for Treating Glioblastoma

@en

P2093

Banishree Saha

http://www.w3.org/2001/XMLSchema#string

Matthew Skinner

http://www.w3.org/2001/XMLSchema#string

Sarah M Ward

http://www.w3.org/2001/XMLSchema#string

P2860

Phase I trial of temozolomide (CCRG 81045: M&B; 39831: NSC 362856)

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple

The blood-brain barrier: an overview: structure, regulation, and clinical implications

CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012.

Disulfide cross-linked phosphorylcholine micelles for triggered release of camptothecin.

Efficacy of polyMPC-DOX prodrugs in 4T1 tumor-bearing mice

Maurocalcine as a non toxic drug carrier overcomes doxorubicin resistance in the cancer cell line MDA-MB 231

Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials.

Antitumor activity and pharmacokinetics in mice of 8-carbamoyl-3-methyl-imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (CCRG 81045; M & B 39831), a novel drug with potential as an alternative to dacarbazine.

P304

5263-5276

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/ACS.MOLPHARMACEUT.8B00766

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Todd Emrick

P577

2018-10-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30354145

http://www.w3.org/2001/XMLSchema#string

P921

drug discovery

molecular medicine

P932

6220362

http://www.w3.org/2001/XMLSchema#string